Penicillamine Tablets USP 250 mg, 100-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202 Manufactured by: Lupin Limited, Nagpur-441 108, India, NDC# 70748-153-01
Published December 20, 2023 · Recall initiated: November 22, 2023
Summary
FDA records drug Class II recall D-0148-2024, published December 20, 2023 and initiated November 22, 2023. Recalling firm: Lupin Pharmaceuticals Inc.; Status: Terminated; Reported quantity: N/A; Lot: Lot # M200498, Exp. June 2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications
What to do
Voluntary: Firm initiated · Letter
Get an email if PENICILLAMINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- PENICILLAMINE
- Manufacturer
- Lupin Pharmaceuticals Inc.
- Distributor
- Product was distributed to 3 wholesale/distributor accounts.
- UPC
- 0370748153017
- Lot
- Lot # M200498, Exp. June 2024
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAVotrient (pazopanib) 200 mg tablets, 120-count bottle, Rx Only, Manufactured by: Siegried Barbera, S.L.,December 20, 2023
- FDALiothyronine Sodium Tablets, USP 5 mcg, 100-count bottle, Rx Only, Distributed by: Sun PharmaceuticalDecember 20, 2023
- FDATYSON 2.0, TYSON TONIC KAVA & KRATOM BLEND, Mocha, 2oz (60ml), Supplement Facts, Kava Root Extract (30%)December 20, 2023
- FDAIntegra Cranial access kit (without Prep solutions) Bit and Guard-For access to the subarachnoid space or theDecember 13, 2023
- FDAvyaire Flexible Patient Circuit, 3100A, REF 29028-004, intended to be used with the 3100A High FrequencyDecember 13, 2023
- FDAAtrium Oasis Dry Suction Water Seal Chest Drain, Part Number: 3650-100, DRAIN, OASIS BRU W/AC, 3650 ATS BLOODDecember 13, 2023
Questions about this recall
Was Penicillamine Tablets USP 250 mg, 100-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202 Manufactured by: Lupin Limited, Nagpur-441 108, India, NDC# 70748-153-01 recalled?
Yes. FDA published recall D-0148-2024 on December 20, 2023. Reported hazard: Failed Dissolution Specifications
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: PENICILLAMINE. UPC: 0370748153017.